SINTX Technologies Signs Supply Agreement With Evonik for Silicon Nitride–PEEK Implant Production

Reuters
Dec 01
SINTX Technologies Signs Supply Agreement With Evonik for Silicon Nitride-PEEK Implant Production

SINTX Technologies Inc. announced that it has signed a supply agreement with Evonik Corporation to manufacture its proprietary silicon nitride-PEEK (SiN/PEEK) compound. This compound is engineered for use in AI-assisted, 3D-printed, patient-specific implants. Under the agreement, Evonik will produce the SiN/PEEK compound according to SINTX's specifications, enabling the immediate production of custom medical devices at SINTX's U.S.-based facility. The company has already received physician requests for humanitarian-use vertebral body replacement implants for oncology patients and intends to use the SiN/PEEK compound to support regulatory clearances of additional implantable devices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SINTX Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9594077-en) on December 01, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10